BeautyHealth Expands Skin Health Ecosystem with Growing Adoption of SkinStylus Nano-Channeling, a Popular Pairing with Hydrafacial Treatments
Rhea-AI Summary
BeautyHealth (NASDAQ: SKIN) announced expanding adoption of its Hydrafacial and SkinStylus Nano-Channeling combination protocol across U.S. aesthetic and wellness providers, citing rising demand for combination treatments that deliver enhanced results with no downtime. The company highlighted provider adoption, a LifeSpa rollout, and survey data showing broad consumer and provider support for combination therapies.
Positive
- Provider adoption accelerating with LifeSpa expanding SkinStylus Nano-Channeling after pilot
- Survey: 77% of providers reported increased client satisfaction with combination programs
- Survey: 81% of consumers believe superior results justify paying more for combination therapy
- 52% of U.S. combination protocols already include microdermabrasion treatments like Hydrafacial
Negative
- Microneedling can cause downtime while nano-channeling does not, potentially limiting some combined uses
- SkinStylus use depends on provider qualification and cartridge selection, requiring training and protocol control
News Market Reaction – SKIN
On the day this news was published, SKIN gained 3.51%, reflecting a moderate positive market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $5M to the company's valuation, bringing the market cap to $138M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers show mixed moves (e.g., HNST +3.9%, HELE -1.79%, NUS +0.93%), with no broad, aligned sector trend, suggesting this news is company-specific rather than a sector rotation.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 26 | Earnings date notice | Neutral | +9.4% | Set reporting date for Q4 and full-year 2025 results and investor call. |
| Dec 04 | Consumer trends report | Neutral | -0.6% | Released third Skintuition report on shifting skin quality preferences and usage. |
| Nov 06 | Q3 2025 earnings | Positive | +8.5% | Reported improved gross margin and narrower net loss despite lower net sales. |
| Nov 03 | Board appointment | Positive | +0.7% | Added experienced aesthetics and consumer health executive to Board committees. |
| Oct 23 | Earnings date notice | Neutral | -2.3% | Announced timing and call details for upcoming Q3 2025 financial results. |
Operational and corporate updates often see modestly positive reactions, while earnings reports have previously drawn stronger upside moves.
Over the past six months, BeautyHealth has alternated between operational updates and financial milestones. An earnings report on Nov 6, 2025 showed lower net sales but improved margins and a narrower net loss, with shares rising 8.53%. Board changes and governance filings in late 2025 added to corporate reshaping. An earnings date announcement on Feb 26, 2026 saw a 9.41% gain. Today’s ecosystem expansion news fits the pattern of product and demand-focused updates within this transformation backdrop.
Market Pulse Summary
This announcement underscores BeautyHealth’s strategy to deepen its professional skin health ecosystem by pairing Hydrafacial with SkinStylus Nano-Channeling, tapping into rising demand for combination protocols. Survey data showing 77% higher provider satisfaction and 81% consumer willingness to pay more highlights the trend backdrop. In assessing this news, investors may track procedure utilization, adoption at partners like LifeSpa, and how these combinations ultimately influence revenue and margins disclosed in future filings.
Key Terms
microdermabrasion medical
microneedling medical
epidermal medical
AI-generated analysis. Not financial advice.
The Hydrafacial Treatment and SkinStylus Nano-Channeling Protocol Addresses Rising Consumer Demand for Combination Treatments That Can Improve Performance and Enhance Results
LONG BEACH, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the expansion of its professional skin health ecosystem through growing adoption of its Hydrafacial treatments and SkinStylus Nano-Channeling combination protocol across leading aesthetic and wellness destinations nationwide.
As demand accelerates for combination protocols that deliver enhanced, visible results without downtime, providers are increasingly pairing Hydrafacial treatments with SkinStylus Nano-Channeling to help elevate treatment performance, improve overall skin quality, and drive stronger client outcomes – while increasing utilization of their existing systems.
Nano-channeling is a gentle, non-invasive cosmetic treatment that creates nano-channels in the outermost layer of the skin to help visually improve the appearance of fine lines, wrinkles, texture, and tone. When performed following a Hydrafacial treatment, SkinStylus Nano-Channeling treatments can enhance exfoliation, help to create a gateway for delivering Hydrafacial serums, promote smoother, more luminous-looking skin, and improve the appearance of fine lines and wrinkles – all with no downtime.
Combination protocols are rapidly becoming the defining trend in medical aesthetics, with 77 percent of providers reporting increased client satisfaction with combination programs, and 81 percent of consumers believing the superior results justify spending more for a combination therapy versus a single treatment.1 In the U.S., 52 percent of combination protocols already include microdermabrasion treatments, such as Hydrafacial treatments.2
“Hydrafacial treatments are not just a single service — they are a platform,” said BeautyHealth Chief Executive Officer Pedro Malha. “As consumer preferences shift toward skin quality and providers seek higher-performance, personalized experiences, combination protocols are becoming standard practice. Expanding SkinStylus microneedling and Nano-Channeling treatments helps strengthen our ecosystem, increases treatment utilization when paired with Hydrafacial treatments, and gives providers another powerful way to elevate results while driving growth.”
The Hydrafacial and SkinStylus Nano-Channeling treatment protocol combines everything clients love about a Hydrafacial treatment with the added benefits of nano-channeling. It begins with a deep cleanse, peel, microdermabrasion exfoliation, and extraction utilizing the Hydrafacial treatment’s wand and proprietary Vortex-Fusion Technology to prep the skin. This is followed by a SkinStylus Nano-Channeling treatment to create controlled nano-channels that help enhance product delivery and overall treatment performance. The treatment concludes with Hydrafacial treatment customizations, such as a booster infusion and LED light therapy, and finally hydration. The results are a comfortable treatment experience, immediate glowing skin, with no downtime.
Provider adoption is accelerating. LifeSpa at Life Time, one of the leading and largest full-service salon and spas in the U.S. and a Hydrafacial partner since 2004, is expanding SkinStylus Nano-Channeling treatments on their service menus in locations across the country following a successful pilot program – offering it as a standalone service and paired with Hydrafacial treatments.
The SkinStylus device can be used for microneedling or nano-channeling treatments depending on the provider’s qualification and experience. The treatments vary based on the cartridge the provider uses and the depth of penetration, with microneedling creating deeper microinjuries on the skin’s surface to help stimulate the skin’s natural collagen and elastin production with the potential for some downtime, and nano-channeling creating more superficial epidermal channels primarily for enhanced product infusion and no downtime.
Learn more by visiting SkinStylus.com.
1BCG. Medical Aesthetics Provider and Consumer Surveys across ~10,000 respondents; BCG analysis. IMCAS. January 2026.
2BCG. Medical Aesthetics Provider and Consumer Surveys across 4,000 respondents; BCG analysis. IMCAS. January 2025.
About The Beauty Health Company
The Beauty Health Company (NASDAQ: SKIN) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial™, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus™ microneedling and HydraScalp powered by Keravive™, BeautyHealth combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide. Learn more at beautyhealth.com or follow us on LinkedIn. Local providers can be found at hydrafacial.com/find-a-hydrafacialist.
Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.
These forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside The Beauty Health Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.
Important factors, among others, that may affect actual results or outcomes include The Beauty Health Company’s ability to execute its business plan; consumers’ perception of skin health, skin concerns, and overall beauty trends, particularly with respect to combination protocols and their efficacy; the continued partnership with Life Time LifeSpa and LifeSpa continuing to offer hydrafacial treatments and/or SkinStylus Nano-Channeling treatments at its locations; potential litigation involving The Beauty Health Company; changes in applicable laws or regulations; and the possibility that The Beauty Health Company may be adversely affected by other economic, business, and/or competitive factors. The Beauty Health Company does not undertake any obligation to update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by law.
Contacts:
Press: press@beautyhealth.com
Investors: IR@beautyhealth.com
Source: BeautyHealth
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/89cb5c79-c34a-4027-a9b5-cbe9ef2f880f.
FAQ
What is the Hydrafacial and SkinStylus Nano-Channeling protocol announced by BeautyHealth (SKIN)?
How widespread is provider and consumer support for combination treatments cited by BeautyHealth (SKIN)?
Will SkinStylus Nano-Channeling cause downtime for clients when paired with Hydrafacial (SKIN)?
Which providers are adopting SkinStylus Nano-Channeling with Hydrafacial (SKIN)?
Does SkinStylus require special training or different settings for nano-channeling versus microneedling with Hydrafacial (SKIN)?